CEDRUS’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $295K | Sell |
1,495
-475
| -24% | -$93.8K | 0.11% | 142 |
|
|
2024
Q2 | $338K | Buy |
1,970
+13
| +0.7% | +$2.23K | 0.17% | 107 |
|
|
2024
Q1 | $356K | Sell |
1,957
-408
| -17% | -$74.3K | 0.19% | 99 |
|
|
2023
Q4 | $367K | Sell |
2,365
-326
| -12% | -$50.5K | 0.23% | 97 |
|
|
2023
Q3 | $401K | Buy |
2,691
+236
| +10% | +$35.2K | 0.29% | 74 |
|
|
2023
Q2 | $331K | Buy |
2,455
+25
| +1% | +$3.37K | 0.23% | 100 |
|
|
2023
Q1 | $387K | Buy |
+2,430
| New | +$387K | 0.27% | 80 |
|